PNW
66
3
ADP
69
-3
T
56
2
ZTS
56
-2
EFX
63
-6
KSS
39
6
COST
56
3
VNO
57
-2
DOV
64
-5
TGT
50
-2
IFF
56
-3
A
44
-2
MAT
51
-3
CMG
51
-3
MUR
50
-2
FIS
46
-4
ILMN
41
-3
NEM
48
2
IP
39
-6
CME
42
-4
PNW
66
3
ADP
69
-3
T
56
2
ZTS
56
-2
EFX
63
-6
KSS
39
6
COST
56
3
VNO
57
-2
DOV
64
-5
TGT
50
-2
IFF
56
-3
A
44
-2
MAT
51
-3
CMG
51
-3
MUR
50
-2
FIS
46
-4
ILMN
41
-3
NEM
48
2
IP
39
-6
CME
42
-4
Financhill
Back

ProShares UltraShort Euro Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
37

EUO
ProShares UltraShort Euro

Last Price:
29.71
Seasonality Move:
2.33%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
37
ProShares UltraShort Euro (EUO) is a Sell

Is ProShares UltraShort Euro a Buy, Sell or Hold?

  • The current ProShares UltraShort Euro [EUO] share price is $29.71. The Score for EUO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • EUO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EUO Stock Price Chart

What is ProShares UltraShort Euro's stock price today?

  • The ProShares UltraShort Euro share price today is $29.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EUO is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

EUO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 40.08 Sell
Chaikin Money Flow: -3530 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.68 - 30.22) Sell
Bollinger Bands (100): (30.21 - 31.47) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

EUO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.98 Sell
20-day SMA: 29.97 Sell
50-day SMA: 30.42 Sell
200-day SMA: 30.65 Sell
8-day EMA: 29.91 Sell
20-day EMA: 30.04 Sell
50-day EMA: 30.35 Sell
200-day EMA: 30.6 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

ProShares UltraShort Euro Earnings Growth & EUO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

ProShares UltraShort Euro Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):